Literature DB >> 26759990

Outer membrane Protein A plays a role in pathogenesis of Acinetobacter nosocomialis.

Sang Woo Kim1,2, Man Hwan Oh3, So Hyun Jun1, Hyejin Jeon1, Seung Il Kim4, Kwangho Kim2, Yoo Chul Lee1, Je Chul Lee1.   

Abstract

Acinetobacter nosocomialis is an important nosocomial pathogen that causes a variety of human infections. However, the specific virulence factors of this microorganism have not yet been determined. We investigated the role of outer membrane protein A (OmpA) in the pathogenesis of A. nosocomialis. A ΔompA mutant of the A. nosocomialis ATCC 17903(T) strain was constructed using markerless gene deletion. The ΔompA mutant displayed reduced biofilm formation in polystyrene tubes and reduced adherence to A549 cells in comparison to the wild-type strain. These virulence traits of the ΔompA mutant strain were restored when the ompA gene was complemented. Cytotoxicity was not significantly different between the wild-type strain and the ΔompA mutant when A549 cells were infected with bacteria or treated with outer membrane vesicles (OMVs). However, OMVs from the wild-type strain induced cytotoxicity in HEp-2 cells, whereas OMVs from the ΔompA mutant did not induce cytotoxicity. Proteomic analysis of OMVs revealed that OmpA influenced the distribution of envelope and periplasmic proteins. Overall, this study is the first report that links OmpA to A. nosocomialis pathogenesis, and highlights OmpA as a putative target to develop anti-virulence agents or vaccines against A. nosocomialis infection.

Entities:  

Keywords:  acinetobacter nosocomialis; biofilm; outer membane protein A; outer membrane vesicles; pathogenesis

Mesh:

Substances:

Year:  2016        PMID: 26759990      PMCID: PMC4871641          DOI: 10.1080/21505594.2016.1140298

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  47 in total

1.  Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors.

Authors:  M-C Chiang; S-C Kuo; S-J Chen; S-P Yang; Y-T Lee; T-L Chen; C-P Fung
Journal:  Infection       Date:  2011-09-02       Impact factor: 3.553

2.  Acinetobacter baumannii outer membrane protein A modulates the biogenesis of outer membrane vesicles.

Authors:  Dong Chan Moon; Chul Hee Choi; Jung Hwa Lee; Chi-Won Choi; Hye-Yeon Kim; Jeong Soon Park; Seung Il Kim; Je Chul Lee
Journal:  J Microbiol       Date:  2012-02-27       Impact factor: 3.422

3.  Acinetobacter baumannii outer membrane protein A induces dendritic cell death through mitochondrial targeting.

Authors:  Jun Sik Lee; Chul Hee Choi; Jung Wook Kim; Je Chul Lee
Journal:  J Microbiol       Date:  2010-06-23       Impact factor: 3.422

4.  Analysis and nucleotide sequence of an origin of DNA replication in Acinetobacter calcoaceticus and its use for Escherichia coli shuttle plasmids.

Authors:  M Hunger; R Schmucker; V Kishan; W Hillen
Journal:  Gene       Date:  1990-03-01       Impact factor: 3.688

5.  Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii.

Authors:  Chen Niu; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

6.  Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.

Authors:  H-W Lee; Y M Koh; J Kim; J-C Lee; Y-C Lee; S-Y Seol; D-T Cho; J Kim
Journal:  Clin Microbiol Infect       Date:  2007-11-13       Impact factor: 8.067

7.  Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins.

Authors:  Sang Woo Kim; Chul Hee Choi; Dong Chan Moon; Jong Sook Jin; Jung Hwa Lee; Ji-Hyun Shin; Jung Min Kim; Yoo Chul Lee; Sung Yong Seol; Dong Taek Cho; Je Chul Lee
Journal:  FEMS Microbiol Lett       Date:  2009-10-13       Impact factor: 2.742

8.  Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii.

Authors:  Lauren B King; Edwin Swiatlo; Andrea Swiatlo; Larry S McDaniel
Journal:  FEMS Immunol Med Microbiol       Date:  2009-02-11

9.  Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles.

Authors:  Jong Sook Jin; Sang-Oh Kwon; Dong Chan Moon; Mamata Gurung; Jung Hwa Lee; Seung Il Kim; Je Chul Lee
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

10.  Species distribution of clinical Acinetobacter isolates revealed by different identification techniques.

Authors:  Jianfeng Wang; Zhi Ruan; Ye Feng; Ying Fu; Yan Jiang; Haiping Wang; Yunsong Yu
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

View more
  5 in total

Review 1.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Roles of ompA of Citrobacter werkmanii in bacterial growth, biocide resistance, biofilm formation and swimming motility.

Authors:  Gang Zhou; Ying-Si Wang; Hong Peng; Su-Juan Li; Ting-Li Sun; Peng-Fei Shen; Xiao-Bao Xie; Qing-Shan Shi
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-25       Impact factor: 4.813

3.  Transcriptional Regulation of the Outer Membrane Protein A in Acinetobacter baumannii.

Authors:  Kyu-Wan Oh; Kyeongmin Kim; Md Maidul Islam; Hye-Won Jung; Daejin Lim; Je Chul Lee; Minsang Shin
Journal:  Microorganisms       Date:  2020-05-11

Review 4.  Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities.

Authors:  Muhammad Asif; Iqbal Ahmad Alvi; Shafiq Ur Rehman
Journal:  Infect Drug Resist       Date:  2018-08-21       Impact factor: 4.003

5.  Acinetobacter nosocomialis: Defining the Role of Efflux Pumps in Resistance to Antimicrobial Therapy, Surface Motility, and Biofilm Formation.

Authors:  Daniel B Knight; Susan D Rudin; Robert A Bonomo; Philip N Rather
Journal:  Front Microbiol       Date:  2018-08-21       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.